Birch Triterpenes Patent Expiration
Birch Triterpenes is Used for treating wounds associated with dystrophic and junctional epidermolysis bullosa. It was first introduced by Chiesi Farmaceutici Spa
Birch Triterpenes Patents
Given below is the list of patents protecting Birch Triterpenes, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Filsuvez | US11083733 | Betulin-containing birch bark extracts and their formulation | Jan 04, 2039 | Chiesi |
| Filsuvez | US11266660 | Betulin-containing birch bark extracts and their formulation | Jan 04, 2039 | Chiesi |
| Filsuvez | US9352041 | Use of an oleogel containing triterpene for healing wounds | Nov 24, 2030 | Chiesi |
| Filsuvez | US9827214 | Use of an oleogel containing triterpene for healing wounds | Nov 24, 2030 | Chiesi |
| Filsuvez | US8828444 | Triterpene-containing oleogel-forming agent, triterpene-containing oleogel and method for producing a triterpene-containing oleogel | Jun 21, 2025 | Chiesi |
Birch Triterpenes's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List